These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11802330)

  • 1. [Irritable bowel syndrome: pathophysiology and (future) treatment options].
    de Schryver AM; Samsom M
    Ned Tijdschr Geneeskd; 2002 Jan; 146(1):12-7. PubMed ID: 11802330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in the treatment of irritable bowel syndrome.
    De Schryver AM; Samsom M
    Scand J Gastroenterol Suppl; 2000; (232):38-42. PubMed ID: 11232489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
    Farthing MJ
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C; Pelosini I
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and its implication for the management of irritable bowel syndrome.
    Gershon MD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S25-34. PubMed ID: 12776000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New directions in the irritable bowel syndrome.
    Bailey LD; Stewart WR; McCallum RW
    Gastroenterol Clin North Am; 1991 Jun; 20(2):335-49. PubMed ID: 2066157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Irritable colon. Physiopathologic and therapeutic aspects].
    Cammarella I; Ruggeri R; Musca A
    Clin Ter; 1992 May; 140(5):473-80. PubMed ID: 1424487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic targets].
    Bueno L
    Gastroenterol Clin Biol; 2009 Feb; 33 Suppl 1():S59-67. PubMed ID: 19303540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tegaserod and other serotonergic agents: what is the evidence?
    Chey WD
    Rev Gastroenterol Disord; 2003; 3 Suppl 2():S35-40. PubMed ID: 12776001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colonic motility in humans. Recent physiological, pathophysiological and pharmacological data].
    Jouët P; Coffin B; Cuillerier E; Soulé JC; Flourié B; Lémann M
    Gastroenterol Clin Biol; 2000 Mar; 24(3):284-98. PubMed ID: 10804335
    [No Abstract]   [Full Text] [Related]  

  • 11. [Irritable bowel syndrome as an interdisciplinary clinical challenge. Current views on its pathophysiology, diagnosis and treatment].
    Hollerbach S; Elsenbruch S; Enck P
    Dtsch Med Wochenschr; 2001 Apr; 126(16):472-8. PubMed ID: 11360454
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A; Boznańska P
    Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic analgesics with potent and selective effects on the gastrointestinal tract: potential application for the treatment of irritable bowel syndrome.
    Mitch CH; Brown TJ; Bymaster FP; Calligaro DO; Dieckman D; Merrit L; Peters SC; Quimby SJ; Shannon HE; Shipley LA; Ward JS; Hansen K; Olesen PH; Sauerberg P; Sheardown MJ; Swedberg MD; Suzdak P; Greenwood B
    J Med Chem; 1997 Feb; 40(4):538-46. PubMed ID: 9046345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of serotonin in the pathophysiology of irritable bowel syndrome.
    Crowell MD
    Am J Manag Care; 2001 Jul; 7(8 Suppl):S252-60. PubMed ID: 11474910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Irritable bowel syndrome: pathophysiology and (future) treatment options].
    Grooff B
    Ned Tijdschr Geneeskd; 2002 Mar; 146(11):540; author reply 540. PubMed ID: 11925818
    [No Abstract]   [Full Text] [Related]  

  • 16. The brain-gut axis in irritable bowel syndrome--clinical aspects.
    Mach T
    Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: clinical evidence to support current therapies of irritable bowel syndrome.
    Camilleri M
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():48-53. PubMed ID: 10429740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer.
    Hirata T; Keto Y; Nakata M; Takeuchi A; Funatsu T; Akuzawa S; Sasamata M; Miyata K
    Neurogastroenterol Motil; 2008 May; 20(5):557-65. PubMed ID: 18221252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Visceral sensitivity and functional bowel disorders: physiopathological role and therapeutic perspectives].
    Delvaux M; Frexinos J
    Gastroenterol Clin Biol; 2001 Sep; 25(2 Pt 2):C42-53. PubMed ID: 11787379
    [No Abstract]   [Full Text] [Related]  

  • 20. Irritable bowel syndrome: an update on treatment options.
    Blackington E
    Adv Nurse Pract; 2000 Oct; 8(10):32-40. PubMed ID: 11761535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.